iRadimed Aktie
WKN DE: A118V4 / ISIN: US46266A1097
05.05.2025 13:56:13
|
Iradimed Corp Bottom Line Rises In Q1
(RTTNews) - Iradimed Corp (IRMD) revealed a profit for its first quarter that increased from last year
The company's bottom line came in at $4.7 million, or $0.37 per share. This compares with $4.1 million, or $0.32 per share, last year.
Excluding items, Iradimed Corp reported adjusted earnings of $5.3 million or $0.42 per share for the period.
The company's revenue for the period rose 10.8% to $19.5 million from $17.6 million last year.
Iradimed Corp earnings at a glance (GAAP) :
-Earnings: $4.7 Mln. vs. $4.1 Mln. last year. -EPS: $0.37 vs. $0.32 last year. -Revenue: $19.5 Mln vs. $17.6 Mln last year.
-Guidance: Next quarter EPS guidance: $0.41 to $0.44 Next quarter revenue guidance: $19.7-$19.9 Mln Full year EPS guidance: $1.71 to $1.81 Full year revenue guidance: $78-$82 Mln

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu iRadimed Corpmehr Nachrichten
04.05.25 |
Ausblick: iRadimed informiert über die jüngsten Quartalsergebnisse (finanzen.net) |
Analysen zu iRadimed Corpmehr Analysen
Aktien in diesem Artikel
iRadimed Corp | 59,00 | 0,85% |
|